Skip to content
Screener

R&D at other companies

TFX
TeleflexTFX
$45.12M+70.3%
UFP Technologies logo
UFP TechnologiesUFPT
$2.15M-17.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$22.61M+0.6%
Medtronic logo
MedtronicMDT
$671M-1.9%
Haemonetics logo
HaemoneticsHAE
$16.2M-0.4%
Stereotaxis logo
StereotaxisSTXS
$2.4M+2.0%

Segments

By segment

See full
Reportable Segment$49.5M-7.3%

Other financials

Income statement

See full
Revenue$439.6M+0.5%
Gross profit$109.6M-8.9%
Operating income$31.9M-35.7%
Net income$16.5M+173%
EPS (diluted)$0.48+173%

Balance sheet

See full
Cash & equivalents$8.1M-74.4%
Total debt$1.4B+2.0%
Total equity$1.7B+5.6%
Total assets$3.4B+3.5%

Cash flow

See full
Operating cash flow$24.7M-21.0%
CapEx$24.0M-5.0%
Free cash flow$737.0K-87.8%

Valuation

See full
Market cap$4.29B+16.1%
Enterprise value$5.66B+13.4%
P/E30.2×-14.4×
P/S2.3×+0.3×

Profitability

See full
Gross margin26.4%-0.6pp
Operating margin11%-1.6pp
Net margin7.6%+3.2pp
FCF margin5.4%-1.0pp

Returns & leverage

See full
Return on equity8.6%+3.7pp
Debt / equity0.8×0.0×
Current ratio3.8×+0.4×

Where this comes from

Reported directly by Integer Holdings in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The source filing: Integer Holdings’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:25 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001114483-26-000015
(in thousands except per share data)Three Months Ended / April 3,2026Three Months Ended / March 28,2025
Gross profit109,595120,318
Operating expenses:
Selling, general and administrative58,71151,160
Research, development and engineering16,24314,201
Restructuring and other charges2,7725,405
Total operating expenses77,72670,766
Operating income31,86949,552
Interest expense9,73414,805

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Integer Holdings's R&D?
Integer Holdings (ITGR) reported R&D of $16.24M in Q1 2026.
How has Integer Holdings's R&D changed year-over-year?
Integer Holdings's R&D increased by 14.4% year-over-year, from $14.2M to $16.24M.
What is the long-term trend for Integer Holdings's R&D?
Over 4 years (2021 to 2025), Integer Holdings's R&D has grown at a -1.2% compound annual growth rate (CAGR), from $51.99M to $49.5M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ask your AI about Integer Holdings's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude